2012		2013		2014		Rate (Cases per 100,000 per month)		Monthly Rate Comparison
Disease	Mar No.	YTD No.	Mar No.	YTD No.	Mar No.	YTD No.	Mar (2009-2013 aggregated)	Mar (2014)	Significant change bet. current & past 5-year?~~
Vaccine Preventable
Diphtheria	0	0	0	0	0	0	0.00	0.00
Haemophilus Influenza (Invasive)	.	.	.	.	.	.	0.08	0.05
Hepatitis A	0	.	.	.	0	.	0.06	0.00	X
Hepatitis B (Acute)	0	10	5	8	0	.	0.11	0.00	X
Influenza**	133	192	74	455	41	381	4.34	2.03	X
Measles	0	0	0	0	0	0	0.00	0.00
Mumps	0	0	0	0	0	0	0.00	0.00
Pertussis	5	8	.	26	0	13	0.10	0.00	X
Poliomyelitis	0	0	0	0	0	0	0.00	0.00
Rubella	0	0	0	0	0	0	0.00	0.00
Tetanus	0	0	0	0	0	0	0.00	0.00
Sexually Transmitted
AIDS	17	58	20	55	13	46	0.96	0.64
Chlamydia	801	2228	735	2215	627	2096	39.96	30.99	X
Gonorrhea	142	407	168	535	126	487	7.88	6.23
HIV	22	65	27	62	12	54	1.08	0.59
Syphilis (Early Latent)	9	46	22	66	10	58	0.68	0.49
Syphilis (Primary & Secondary)	8	20	10	29	6	52	0.40	0.30
Enterics
Amebiasis	.	.	0	.	0	0	0.03	0.00
Botulism-Intestinal (Infant)	0	0	0	0	0	0	0.00	0.00
Campylobacteriosis	.	18	5	15	.	22	0.39	0.20
Cholera	0	0	0	0	0	0	0.00	0.00
Cryptosporidiosis	.	.	.	.	0	0	0.03	0.00
Giardia	.	12	.	11	.	.	0.19	0.10
Rotavirus	.	.	13	38	.	7	0.37	0.20
Salmonellosis	10	24	11	29	.	15	0.47	0.20
Shiga-Toxin Producing E.COLI#	.	12	.	6	0	.	0.18	0.00	X
Shigellosis	0	.	.	10	0	.	0.11	0.00	X
Typhoid Fever	0	0	0	0	0	0	0.00	0.00
Vibrio (Non-Cholera)	0	0	0	0	0	.	0.00	0.00
Yersiniosis	.	.	0	.	0	.	0.01	0.00
Other
Anthrax	0	0	0	0	0	0	0.00	0.00
Botulism Intoxication	0	0	0	0	0	0	0.00	0.00
Brucellosis	0	0	0	0	0	0	0.00	0.00
Coccidioidomycosis	10	33	8	15	.	15	0.38	0.15
Dengue Fever	0	0	.	.	0	0	0.01	0.00
Encephalitis	0	0	0	.	0	0	0.00	0.00
Hantavirus	0	0	0	0	0	0	0.00	0.00
Hemolytic Uremic Syndrome (HUS)	0	0	0	0	0	0	0.01	0.00
Hepatitis C (Acute)	.	.	0	0	0	0	0.03	0.00
Hepatitis D	0	0	0	0	0	0	0.00	0.00
Invasive Group A Strep.##	0	0	0	0	0	0	0.04	0.00
Legionellosis	.	.	.	.	0	.	0.08	0.00	X
Leprosy (Hansen’s Disease)	0	0	0	0	0	0	0.00	0.00
Leptospirosis	0	0	0	0	0	0	0.00	0.00
Listeriosis	0	.	0	.	0	0	0.00	0.00
Lyme Disease	0	.	0	0	0	0	0.00	0.00
Malaria	0	.	0	.	0	0	0.01	0.00
Meningitis, Aseptic/Viral	0	.	.	5	.	6	0.08	0.10
Meningitis Bacterial	.	.	0	.	.	.	0.04	0.15
Meningococcal Disease	0	.	0	0	.	.	0.02	0.05
Plague	0	0	0	0	0	0	0.00	0.00
Psittacosis	0	0	0	0	0	0	0.00	0.00
Q Fever	0	0	0	0	0	0	0.00	0.00
Rabies (Human)	0	0	0	0	0	0	0.00	0.00
Relapsing Fever	0	0	0	0	0	0	0.00	0.00
Rocky Mountain Spotted Fever	0	0	0	0	0	0	0.00	0.00
RSV (Respiratory Syncytial Virus)	173	685	219	1077	130	475	9.38	6.43	X
Streptococcus Pneumoniae IPD###	6	18	.	20	5	23	0.22	0.25
Toxic Shock Syn.	0	0	0	0	0	0	0.00	0.00
Toxic Shock Syn. (Streptococcal)	.	.	0	.	.	.	0.01	0.10
Tuberculosis	7	22	9	18	9	12	0.36	0.44
Tularemia	0	0	0	0	0	0	0.00	0.00
Unusual Illness	0	0	0	0	0	0	0.00	0.00
West Nile Virus (Encephalitis)	0	0	0	0	0	0	0.00	0.00
West Nile Virus (Fever)	0	0	0	0	0	0	0.00	0.00

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Ja including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Data suppression denoted by ‘.’ applies if number of cases <5. Monthly disease total reported by OOE=202(reported total=1005). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported monthly cases [suppression applied] for 2012-2014 were respectively 0,0,0; YTD totals 0,.,.).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the monthly disease incidence rates provided a basis for an informal statistical test to determine if the current monthly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current month of this year or previous 5 years aggregated).